Fundraising FoxCardior Pharmaceuticals GmbH
7 known investors
Find your way into Cardior Pharmaceuticals GmbH
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Investors · 7
BioMedPartnerslisted by BioMedPartnersBasel · $648K – $6.5M
How we know: BioMedPartners's portfolio page · funding news · press coverage · the VCSheet dataset · Not right? Tell us
coparionlisted by coparionCologne · $550K – $16.5M
How we know: coparion's portfolio page · press coverage · Not right? Tell us
Hadean Ventureslisted by Hadean VenturesOslo
How we know: Hadean Ventures's portfolio page · press coverage · Not right? Tell us
Inkeflisted by InkefAmsterdam
How we know: Inkef's portfolio page · a partner's Signal profile · press coverage · the VCSheet dataset · Not right? Tell us
Fund+reportedLeuven · $5.5M – $16.5M
How we know: press coverage · Not right? Tell us
LSP (Life Sciences Partners)reportedAmsterdam · $11M – $66M
How we know: funding news · Not right? Tell us
Sunstone CapitalreportedFrederiksberg
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Cardior Pharmaceuticals GmbH do?
- Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
- Who are Cardior Pharmaceuticals GmbH's investors?
- Cardior Pharmaceuticals GmbH's investors include BioMedPartners, coparion, Hadean Ventures, Inkef, Fund+, LSP (Life Sciences Partners), Sunstone Capital.